Article
Integrative Pharmacogenomics Analysis of Patient Derived Xenografts
2018-11-16
Abstract excerpt
<h4>ABSTRACT</h4> One of the key challenges in cancer precision medicine is finding robust biomarkers of drug response. Patient-derived tumor xenografts (PDXs) have emerged as reliable preclinical models since they better recapitulate tumor response to chemo- and targeted therapies. However, the lack of standard tools poses a challenge in the analysis of PDXs with molecular and pharmacological profiles. Efficient...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c009516e-e7fb-5315-8a8e-41aedfa17458
- DOI
- 10.1101/471227
